Management and conduct of randomized controlled trials

Epidemiologic Reviews

Volumn 24, Issue 1, 2002, Pages 12-25

  Knatterud, Genell L ^a  

^a MARYLAND MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; INFORMATION PROCESSING; META ANALYSIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICS; EPIDEMIOLOGY; METHODOLOGY; PRACTICE GUIDELINE; STANDARD;

BIAS (EPIDEMIOLOGY); DATA COLLECTION; GUIDELINE ADHERENCE; HUMAN; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; HUMANS;

EID: 0036018990     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/epirev/24.1.12     Document Type: Review

References (31)

1. The clinical trial
2. Design of data forms
3. How much data should be collected in a clinical trial? Experience of the Coronary Drug Project
4. An examination of the efficacy of some quality assurance methods commonly employed in clinical trials
5. Verifying keyed medical record data
6. Double data entry: What value, what price?
7. Recruitment for controlled clinical trials: Literature summary and annotated bibliography
8. Recruitment of participants for the Estrogen Replacement and Atherosclerosis (ERA) trial: A comparison of costs, yields, and participant characteristics from community- and hospital-based recruitment strategies
9. Identifying high yield sources of patients with coronary artery disease for clinical trials: Lessons from the Asymptomatic Cardiac Ischemia Pilot (ACIP) experience
10. A randomized controlled trial of aspirin in persons recovered from myocardial infarction
11. Successful program for recovery of dropouts to a clinical trial
12. Dropouts from a clinical trial, their recovery and characterization: A basis for dropout management and prevention
13. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-Week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
14. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts
15. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project
16. Guidelines for quality assurance in multicenter trials: A position paper
17. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials
18. Persantine-Aspirin Reinfarction Study. Design, methods and baseline results
19. Preface
20. Operational aspects of terminating the doxazosin of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
21. Closeout of four phase II Vanguard trials and patient rollover into a large international phase II HIV Clinical endpoint trial
22. The closeout process for a clinical trial terminated early for lagging enrollment and inadequate follow-up
23. Obtaining event status at the close of the Treatment of Mild Hypertension Study: Methods and implication for other trials
24. Patient notification and follow-up after suspension of treatment protocols: Experience from four clinical trials of treatments for AIDS-related CMV retinitis
25. The field trial: Some thoughts on the indispensable ordeal